Answer
Bylvay (odevixibat sesquihydrate) is contraindicated in patients with hypersensitivity to the active substance or any excipient listed in section 6.1 of its SmPC.
Sources for this answer
- Bylvay 200 micrograms hard capsulesIpsen Ltd · emc · SmPC §4.3 Contraindications · Version 5Document updated
Sources checked